Raymond James & Associates’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | $238M | Sell |
|
|||||
|
2024
Q2 | $239M | Sell |
|
|||||
|
2024
Q1 | $243M | Buy |
|
|||||
|
2023
Q4 | $226M | Sell |
|
|||||
|
2023
Q3 | $286M | Sell |
|
|||||
|
2023
Q2 | $321M | Sell |
|
|||||
|
2023
Q1 | $361M | Buy |
|
|||||
|
2022
Q4 | $438M | Buy |
|
|||||
|
2022
Q3 | $359M | Buy |
|
|||||
|
2022
Q2 | $421M | Buy |
|
|||||
|
2022
Q1 | $412M | Buy |
|
|||||
|
2021
Q4 | $438M | Sell |
|
|||||
|
2021
Q3 | $325M | Sell |
|
|||||
|
2021
Q2 | $341M | Buy |
|
|||||
|
2021
Q1 | $295M | Sell |
|
|||||
|
2020
Q4 | $324M | Sell |
|
|||||
|
2020
Q3 | $355M | Sell |
|
|||||
|
2020
Q2 | $342M | Sell |
|
|||||
|
2020
Q1 | $481M | Buy |
|
|||||
|
2019
Q4 | $564M | Buy |
|
|||||
|
2019
Q3 | $452M | Buy |
|
|||||
|
2019
Q2 | $459M | Buy |
|
|||||
|
2019
Q1 | $417M | Sell |
|
|||||
|
2018
Q4 | $443M | Sell |
|
|||||
|
2018
Q3 | $480M | Buy |
|
|||||
|
2018
Q2 | $383M | Buy |
|
|||||
|
2018
Q1 | $341M | Buy |
|
|||||
|
2017
Q4 | $334M | Buy |
|
|||||
|
2017
Q3 | $316M | Buy |
|
|||||
|
2017
Q2 | $286M | Buy |
|
|||||
|
2017
Q1 | $274M | Buy |
|
|||||
|
2016
Q4 | $240M | Buy |
|
|||||
|
2016
Q3 | $231M | Buy |
|
|||||
|
2016
Q2 | $202M | Buy |
|
|||||
|
2016
Q1 | $159M | Sell |
|
|||||
|
2015
Q4 | $178M | Buy |
|
|||||
|
2015
Q3 | $154M | Buy |
|
|||||
|
2015
Q2 | $149M | Buy |
|
|||||
|
2015
Q1 | $132M | Buy |
|
|||||
|
2014
Q4 | $105M | Buy |
|
|||||
|
2014
Q3 | $66.3M | Buy |
|
|||||
|
2014
Q2 | $65.4M | Buy |
|
|||||
|
2014
Q1 | $67.2M | Buy |
|
|||||
|
2013
Q4 | $61.5M | Sell |
|
|||||
|
2013
Q3 | $63.6M | Buy |
|
|||||
|
2013
Q2 | $58.7M | Buy |
|